Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDKG-TE1D trial for Parkinson's disease
jRCT2012260054Phase 3Not yet recruiting
- Sponsor
- mediVR
- Start
- Oct 2026
- Countries
- 1
01
Overview
Phase 3 trial in Parkinson's disease (PD), sponsored by mediVR. Primary endpoint: TUG Comfortable Walking Speed. Planned start Oct 2026; status: not yet recruiting.
02
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2012260054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2012260054.